ReferenceRRK5584

The REGENERATE Study

A Phase 3 Double-Blind Randomized Long-Term Placebo-Controlled Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in Subjects with Nonalcoholic Steatohepatitis

Research Summary

Research Overview
PI Name Newsome - P
Speciality
Sponsor Intercept Pharmaceuticals
Project Status Open
Proposed End Date 30/06/2024
Study Run through CRF? No
Target number of patients agreed to recruit 5
Recruitment so far 6